Nik Krajnc

665 total citations
49 papers, 313 citations indexed

About

Nik Krajnc is a scholar working on Pathology and Forensic Medicine, Neurology and Ophthalmology. According to data from OpenAlex, Nik Krajnc has authored 49 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pathology and Forensic Medicine, 30 papers in Neurology and 12 papers in Ophthalmology. Recurrent topics in Nik Krajnc's work include Multiple Sclerosis Research Studies (33 papers), Cerebral Venous Sinus Thrombosis (14 papers) and Peripheral Neuropathies and Disorders (12 papers). Nik Krajnc is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Cerebral Venous Sinus Thrombosis (14 papers) and Peripheral Neuropathies and Disorders (12 papers). Nik Krajnc collaborates with scholars based in Austria, Slovenia and Germany. Nik Krajnc's co-authors include Gabriel Bsteh, Thomas Berger, Berthold Pemp, Stefan Macher, Fritz Leutmezer, Paulus Rommer, Christian Wöber, Gudrun Zulehner, Jan Mareš and Hans‐Peter Hartung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Nik Krajnc

41 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nik Krajnc Austria 11 178 162 63 40 38 49 313
Elvira Sbragia Italy 10 202 1.1× 83 0.5× 23 0.4× 44 1.1× 17 0.4× 25 261
Saeed Vaheb Iran 9 177 1.0× 130 0.8× 17 0.3× 21 0.5× 81 2.1× 45 248
Tuncay Gündüz Türkiye 9 57 0.3× 69 0.4× 57 0.9× 25 0.6× 13 0.3× 41 209
J. Gracia Gil Spain 6 103 0.6× 145 0.9× 19 0.3× 15 0.4× 75 2.0× 9 236
R. F. Neuteboom Netherlands 8 269 1.5× 221 1.4× 25 0.4× 83 2.1× 24 0.6× 11 334
Tim Lotze United States 6 199 1.1× 182 1.1× 9 0.1× 58 1.4× 20 0.5× 11 305
Verónica Rivas‐Alonso Mexico 9 151 0.8× 137 0.8× 13 0.2× 35 0.9× 11 0.3× 29 290
Abir Wahab France 6 226 1.3× 241 1.5× 15 0.2× 15 0.4× 204 5.4× 13 436
Robert A Bermel United States 7 271 1.5× 124 0.8× 7 0.1× 62 1.6× 26 0.7× 12 349
Reza Vosoughi Canada 9 194 1.1× 107 0.7× 7 0.1× 55 1.4× 29 0.8× 22 354

Countries citing papers authored by Nik Krajnc

Since Specialization
Citations

This map shows the geographic impact of Nik Krajnc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nik Krajnc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nik Krajnc more than expected).

Fields of papers citing papers by Nik Krajnc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nik Krajnc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nik Krajnc. The network helps show where Nik Krajnc may publish in the future.

Co-authorship network of co-authors of Nik Krajnc

This figure shows the co-authorship network connecting the top 25 collaborators of Nik Krajnc. A scholar is included among the top collaborators of Nik Krajnc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nik Krajnc. Nik Krajnc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berek, Klaus, Michael Auer, Franziska Di Pauli, et al.. (2025). Impact of renal function impairment on kappa free light chain index. Clinical Chemistry and Laboratory Medicine (CCLM). 63(9). 1792–1799. 2 indexed citations
2.
Bsteh, Gabriel, Harald Hegen, Nik Krajnc, et al.. (2025). Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis. Neurology. 105(8). e214069–e214069.
3.
Ponleitner, Markus, Nik Krajnc, Tobias Zrzavy, et al.. (2025). Safety of disease-modifying therapies in multiple sclerosis: real-world data from the Austrian MS Treatment Registry (AMSTR). Journal of Neurology. 272(12). 774–774.
4.
Bsteh, Gabriel, Stefan Macher, Nik Krajnc, et al.. (2024). An interdisciplinary integrated specialized one‐stop outpatient clinic for idiopathic intracranial hypertension—a comprehensive assessment of clinical outcome. European Journal of Neurology. 31(10). e16401–e16401. 3 indexed citations
5.
Bsteh, Gabriel, Nik Krajnc, Patrick Altmann, et al.. (2024). Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?. European Journal of Neurology. 31(12). e16526–e16526. 2 indexed citations
6.
Bsteh, Gabriel, Nik Krajnc, Anke Salmen, et al.. (2024). Disability progression is a question of definition—A methodological reappraisal by example of primary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 93. 106215–106215. 1 indexed citations
7.
Zrzavy, Tobias, Kerstin Rieder, Renate Thalhammer, et al.. (2024). Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS. Frontiers in Neurology. 15. 1388941–1388941. 1 indexed citations
8.
Krajnc, Nik, Stefan Macher, Nina Müller, et al.. (2024). Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension. The Journal of Headache and Pain. 25(1). 145–145. 1 indexed citations
9.
Krajnc, Nik, Fritz Leutmezer, Markus Ponleitner, et al.. (2024). Autoimmune screening panel in patients with multiple sclerosis: A Vienna multiple sclerosis database study. European Journal of Neurology. 32(1). e16558–e16558.
10.
Mitsch, Christoph, Stefan Macher, Nik Krajnc, et al.. (2023). The Vienna idiopathic intracranial hypertension database—An Austrian registry. Wiener klinische Wochenschrift. 136(1-2). 32–39. 10 indexed citations
11.
Ludwig, Birgit, Nik Krajnc, Stefan Macher, et al.. (2023). Reported neurological symptoms after severe acute respiratory syndrome coronavirus type 2 infection: A systematic diagnostic approach. European Journal of Neurology. 30(9). 2713–2725. 5 indexed citations
12.
Bsteh, Gabriel, Stefan Macher, Nik Krajnc, et al.. (2023). Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. Headache The Journal of Head and Face Pain. 63(5). 601–610. 10 indexed citations
13.
Krajnc, Nik, Assunta Dal‐Bianco, Tobias Zrzavy, et al.. (2023). Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis. Acta Neuropathologica. 146(5). 707–724. 22 indexed citations
14.
Bsteh, Gabriel, Harald Hegen, Patrick Altmann, et al.. (2023). Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis. European Journal of Neurology. 30(4). 1025–1034. 9 indexed citations
15.
Bsteh, Gabriel, Harald Hegen, Patrick Altmann, et al.. (2023). Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple Sclerosis. Neurology. 101(8). e784–e793. 23 indexed citations
16.
Berek, Klaus, Harald Hegen, Michael Auer, et al.. (2023). Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis. Multiple Sclerosis Journal. 30(1). 55–62. 1 indexed citations
17.
Bsteh, Gabriel, Nik Krajnc, Patrick Altmann, et al.. (2022). Retinal Layer Thinning After Optic Neuritis Is Associated With Future Relapse Remission in Relapsing Multiple Sclerosis. Neurology. 99(16). e1803–e1812. 3 indexed citations
18.
Bsteh, Gabriel, Nik Krajnc, Franziska Di Pauli, et al.. (2022). Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study. European Journal of Neurology. 29(10). 3050–3060. 20 indexed citations
19.
Bsteh, Gabriel, Harald Hegen, Nik Krajnc, et al.. (2022). Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study. European Journal of Neurology. 29(5). 1538–1544. 15 indexed citations
20.
Bsteh, Gabriel, Harald Hegen, Franziska Di Pauli, et al.. (2022). Impact of vaccination on COVID‐19 outcome in multiple sclerosis. European Journal of Neurology. 29(11). 3329–3336. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elvira Sbragia Breakdown of academic impact, for papers by Saeed Vaheb Breakdown of academic impact, for papers by Tuncay Gündüz Breakdown of academic impact, for papers by J. Gracia Gil Breakdown of academic impact, for papers by R. F. Neuteboom Breakdown of academic impact, for papers by Tim Lotze Breakdown of academic impact, for papers by Verónica Rivas‐Alonso Breakdown of academic impact, for papers by Abir Wahab Breakdown of academic impact, for papers by Robert A Bermel Breakdown of academic impact, for papers by Reza Vosoughi
Rankless by CCL
2026